Pharmacology Watch – December 1, 2015
December 1, 2015
View Archives Issues
-
Rethinking Calcium Supplementation
Increasing calcium intake from dietary sources or supplements produces small, non-progressive increases in bone mineral density, which are unlikely to make a clinically significant reduction in fracture.
-
FDA Actions
FDA approves reversal agents, signs off on schizophrenia drug, warns of liver damage associated with hepatitis C treatment, green lights hyperkalemia treatment, and approves the first oncolytic virus for the treatment of melanoma.